VeriMomdi-c12-15 pareth-4 phosphate est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard listing found for di-C12-15 pareth-4 phosphate. No published reproductive toxicity or human teratogenicity data identified in authoritative reviews; as a surfactant/ethoxylated fatty alcohol phosphate, there is no specific mechanism for reproductive toxicity reported. Dermal cosmetic use gives low but measurable potential for minimal systemic exposure (typical for anionic surfactants), so exposure scored as low. Sources consulted: ECHA Annex VI (no harmonised classification), PubChem/CosIng entries (ingredient identity/uses), literature databases (no specific reproductive studies found).
Pregnancy-safe products containing di-c12-15 pareth-4 phosphate
Related ingredients
Frequently asked questions
- di-c12-15 pareth-4 phosphate est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard listing found for di-C12-15 pareth-4 phosphate. No published reproductive toxicity or human teratogenicity data identified in authoritative reviews; as a surfactant/ethoxylated fatty alcohol phosphate, there is no specific mechanism for reproductive toxicity reported. Dermal cosmetic use gives low but measurable potential for minimal systemic exposure (typical for anionic surfactants), so exposure scored as low. Sources consulted: ECHA Annex VI (no harmonised classification), PubChem/CosIng entries (ingredient identity/uses), literature databases (no specific reproductive studies found).
- di-c12-15 pareth-4 phosphate est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no authoritative reproductive/breast‑milk transfer hazards identified. Low but measurable systemic exposure from topical use is possible but no data demonstrating transfer in milk. Sources: ECHA Annex VI, PubChem, CosIng; no SCCS/CIR hazard finding.
- di-c12-15 pareth-4 phosphate est-il sûr pour la peau de bébé ?
- No infant-specific reproductive or developmental toxicity data found. Because infant skin has a higher surface‑area‑to‑weight ratio and an immature barrier, topical exposure was up‑rated by +1 relative to adult exposure (adult e=1 → infant e=2). No evidence indicates increased mechanistic hazard for infants. Sources: CosIng/PubChem for ingredient use and identity; no SCCS/CIR concerns or ECHA harmonised classification.
- Comment VeriMom évalue-t-il di-c12-15 pareth-4 phosphate ?
- VeriMom évalue di-c12-15 pareth-4 phosphate à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à di-c12-15 pareth-4 phosphate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à di-c12-15 pareth-4 phosphate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.